Adient plc
NYSE:ADNTAuto - Parts
+$0.21 today
- Market cap
- $1.15B
- Beta
- 1.51
- P/E (TTM)
- 27.8
- EPS (TTM)
- $0.74
Volume 1.72M
Average 0.97M
ADNT Common Stock Repurchased
Cash spent buying back the company's own shares.
Adient plcNYSE: ADNT
Common Stock Repurchased · Q2 FY2026 · quarter ended Mar 2026
Common stock repurchased outflow grows to $0
Q2 FY2026 common stock repurchased was $0, compared with $0 a year earlier. Trailing-twelve-month common stock repurchased was -$125M.
Context
- Common stock repurchased amounted to 0.9% of revenue in FY2025, down 1.0 pp from a year earlier.
- Common stock repurchased increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly common stock repurchased holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$31.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Repurchased history
USD · from the cash flow
- Latest · FY2025
- (125M) USD
- Year-over-year change
- +54.5%
| Period | Period end | Common Stock Repurchased | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | (125M) | +54.5% |
| FY2024 | 2024-09-30 | (275M) | -323.1% |
| FY2023 | 2023-09-30 | (65M) | — |
| FY2022 | 2022-09-30 | 0 | — |
| FY2021 | 2021-09-30 | 0 | — |
Common Stock Repurchased vs competitors
How ADNT compares with its peers on the latest reported figures
- ADNT's LTM Mar 2026 common stock repurchased of $125M is the 5th largest of the 14 companies compared; the peer median is $11.35M.
- Its year-over-year change of -16.7% is the 8th highest of 13, against a peer median of +51.9%.
- Common stock repurchased amounts to 0.8% of revenue for ADNT, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $562M | +118.7% | +196.2% | — | |
| LTM Oct 2026 | $525.1M | +105.1% | +48.0% | 2.2% | |
| LTM Jun 2026 | $450M | +35.1% | +45.1% | 4.1% | |
| LTM Jun 2026 | $254.5M | -19.7% | +41.0% | 9.7% | |
| LTM Mar 2026 | $125M | -16.7% | — | 0.8% | |
| LTM Sep 2026 | $112M | -72.2% | +5.7% | 2.5% | |
| LTM Jun 2026 | $86M | +68.6% | — | 2.3% | |
| LTM Mar 2026 | $11.35M | +314.9% | — | 1.4% | |
| LTM Mar 2026 | $3M | — | -0.0% | 0.4% | |
| LTM Apr 2026 | $1.22M | -35.0% | -32.6% | 0.1% | |
| LTM Mar 2026 | $823K | +160.4% | — | 0.1% | |
| LTM Mar 2026 | $283K | -96.5% | — | 0.0% | |
| LTM Mar 2026 | $121K | -69.8% | -24.5% | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding ADNT) | $11.35M | +51.9% | +23.3% | 0.9% | |
Competitors are the stored peer set for ADNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 1.11B | (40M) | 295M | 101M | (281M) |
| Depreciation & Amortization | 330M | 350M | 340M | 332M | 325M |
| Deferred Income Tax | 40M | (25M) | (124M) | (1M) | (28M) |
| Stock-Based Compensation | 0 | 29M | 34M | 31M | 0 |
| Change in Working Capital | (227M) | (108M) | 126M | 75M | (45M) |
| Accounts Receivables | 483M | (576M) | 16M | 12M | 31M |
| Inventory | (263M) | (62M) | 126M | 93M | 75M |
| Accounts Payables | (388M) | 558M | (19M) | 90M | (61M) |
| Other Working Capital | (59M) | (28M) | 3M | (120M) | (90M) |
| Other Non-Cash Items | (991M) | 68M | (4M) | 5M | 478M |
| Operating Cash Flow | 260M | 274M | 667M | 543M | 449M |
| Capital Expenditures | (260M) | (227M) | (252M) | (266M) | (245M) |
| Acquisitions (Net) | 604M | 721M | (1M) | (2M) | 88M |
| Purchases of Investments | 0 | (30M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 3M | 20M | 24M | 15M | (29M) |
| Investing Cash Flow | 347M | 484M | (229M) | (253M) | (186M) |
| Debt Repayment | (694M) | (1B) | (103M) | (138M) | (20M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (65M) | (275M) | (125M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (76M) | (272M) | (103M) | (89M) | (122M) |
| Financing Cash Flow | (770M) | (1.27B) | (271M) | (502M) | (267M) |
| Effect of Forex Changes | (8M) | (59M) | (4M) | 47M | 17M |
| Net Change in Cash | (171M) | (574M) | 163M | (165M) | 13M |
| Free Cash Flow | 0 | 47M | 415M | 277M | 204M |
Adient plc
NYSE:ADNT
Intrinsic Alpha fair value
Locked
Current Price
$15.44
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.